ArticleBMC gastroenterology2019

The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis.

Rikke Hjortebjerg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.